BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rohm M, Zeigerer A, Machado J, Herzig S. Energy metabolism in cachexia. EMBO Rep 2019;20:e47258. [PMID: 30890538 DOI: 10.15252/embr.201847258] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 21.7] [Reference Citation Analysis]
Number Citing Articles
1 Di Girolamo D, Tajbakhsh S. Pathological features of tissues and cell populations during cancer cachexia. Cell Regen 2022;11:15. [DOI: 10.1186/s13619-022-00108-9] [Reference Citation Analysis]
2 Wei L, Wang R, Wazir J, Lin K, Song S, Li L, Pu W, Zhao C, Wang Y, Su Z, Wang H. 2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle. Cells 2022;11:2987. [DOI: 10.3390/cells11192987] [Reference Citation Analysis]
3 Moga TD, Moga I, Sabău M, Venter AC, Romanescu D, Bimbo-szuhai E, Costas LM, Huniadi A, Rahota DM. Evaluation of Geriatric Sarcopenia and Nutrition in the Case of Cachexia before Exitus: An Observational Study for Health Professionals. Geriatrics 2022;7:102. [DOI: 10.3390/geriatrics7050102] [Reference Citation Analysis]
4 Aguilar-cazares D, Chavez-dominguez R, Marroquin-muciño M, Perez-medina M, Benito-lopez JJ, Camarena A, Rumbo-nava U, Lopez-gonzalez JS. The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment. Front Endocrinol 2022;13:929572. [DOI: 10.3389/fendo.2022.929572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang B, Bi Q, Huang S, Lv S, Zong X, Wang M, Ji X. Baoyuan Jiedu decoction alleviating cancer cachexia–Induced muscle atrophy by regulating muscle mitochondrial function in ApcMin/+ mice. Front Pharmacol 2022;13:914597. [DOI: 10.3389/fphar.2022.914597] [Reference Citation Analysis]
6 Holder ER, Alibhai FJ, Caudle SL, McDermott JC, Tobin SW. The importance of biological sex in cardiac cachexia. Am J Physiol Heart Circ Physiol 2022. [PMID: 35960634 DOI: 10.1152/ajpheart.00187.2022] [Reference Citation Analysis]
7 Hitachi K, Honda M, Tsuchida K. The Functional Role of Long Non-Coding RNA in Myogenesis and Skeletal Muscle Atrophy. Cells 2022;11:2291. [PMID: 35892588 DOI: 10.3390/cells11152291] [Reference Citation Analysis]
8 Beltrà M, Pöllänen N, Fornelli C, Tonttila K, Hsu MY, Zampieri S, Moletta L, Porporato PE, Kivelä R, Sandri M, Hulmi JJ, Sartori R, Pirinen E, Penna F. NAD+ repletion with niacin counteracts cancer cachexia.. [DOI: 10.1101/2022.07.06.499010] [Reference Citation Analysis]
9 Olaechea S, Gannavarapu BS, Alvarez C, Gilmore A, Sarver B, Xie D, Infante R, Iyengar P. Primary Tumor Fluorine‐18 Fluorodeoxydglucose (18F‐FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse Survival. Front Oncol 2022;12:900712. [DOI: 10.3389/fonc.2022.900712] [Reference Citation Analysis]
10 Zeng R, Tong C, Xiong X. The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer Cachexia. Cancers (Basel) 2022;14:2955. [PMID: 35740622 DOI: 10.3390/cancers14122955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cirillo F, Zimmers TA, Mangiavini L. Editorial: Metabolic Adaptation of Muscle Tissue in Diseases Associated With Cachexia. Front Cell Dev Biol 2022;10:947902. [DOI: 10.3389/fcell.2022.947902] [Reference Citation Analysis]
12 Manirambona E, Gunawardana S, Hathaway H, Lakhoo K, Ford K, Kanyamuhunga A. A comparison of nutritional status in patients with neuroblastoma in Rwanda and United Kingdom: a cross-sectional observational study conducted by the OxPLORE collaboration. Ann Pediatr Surg 2022;18. [DOI: 10.1186/s43159-022-00176-1] [Reference Citation Analysis]
13 Xu X, Jiang X, Xu Q, Xu H, Luo J, Yao C, Ding L, Zhu S. Skeletal Muscle Change During Neoadjuvant Therapy and Its Impact on Prognosis in Patients With Gastrointestinal Cancers: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:892935. [DOI: 10.3389/fonc.2022.892935] [Reference Citation Analysis]
14 Ahmad SS, Ahmad K, Shaikh S, You HJ, Lee EY, Ali S, Lee EJ, Choi I. Molecular Mechanisms and Current Treatment Options for Cancer Cachexia. Cancers (Basel) 2022;14:2107. [PMID: 35565236 DOI: 10.3390/cancers14092107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Marzetti E, Picca A, Tummolo AM, Calvani R. Cachexia. Pathy's Principles and Practice of Geriatric Medicine 2022. [DOI: 10.1002/9781119484288.ch99] [Reference Citation Analysis]
16 Divella R, Gadaleta Caldarola G, Mazzocca A. Chronic Inflammation in Obesity and Cancer Cachexia. JCM 2022;11:2191. [DOI: 10.3390/jcm11082191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Molfino A, Belli R, Imbimbo G, Carletti R, Amabile MI, Tambaro F, di Gioia CRT, Belloni E, Ferraro E, Nigri G, Muscaritoli M. Evaluation of Browning Markers in Subcutaneous Adipose Tissue of Newly Diagnosed Gastrointestinal Cancer Patients with and without Cachexia. Cancers (Basel) 2022;14:1948. [PMID: 35454855 DOI: 10.3390/cancers14081948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gáliková M, Klepsatel P. Endocrine control of glycogen and triacylglycerol breakdown in the fly model. Semin Cell Dev Biol 2022:S1084-9521(22)00116-1. [PMID: 35393234 DOI: 10.1016/j.semcdb.2022.03.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kim GT, Kim EY, Shin SH, Lee H, Lee SH, Park K, Sohn KY, Yoon SY, Kim JW. PLAG alleviates cisplatin-induced cachexia in lung cancer implanted mice. Transl Oncol 2022;20:101398. [PMID: 35339890 DOI: 10.1016/j.tranon.2022.101398] [Reference Citation Analysis]
20 Joshi M, Patel BM. The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia. Mol Cell Biochem. [DOI: 10.1007/s11010-022-04398-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Xie H, Heier C, Meng X, Bakiri L, Pototschnig I, Tang Z, Schauer S, Baumgartner VJ, Grabner GF, Schabbauer G, Wolinski H, Robertson GR, Hoefler G, Zeng W, Wagner EF, Schweiger M, Zechner R. An immune-sympathetic neuron communication axis guides adipose tissue browning in cancer-associated cachexia. Proc Natl Acad Sci U S A 2022;119:e2112840119. [PMID: 35210363 DOI: 10.1073/pnas.2112840119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
22 Cui P, Li X, Huang C, Li Q, Lin D. Metabolomics and its Applications in Cancer Cachexia. Front Mol Biosci 2022;9:789889. [DOI: 10.3389/fmolb.2022.789889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Huot JR, Pin F, Bonetto A. Therapy-Induced Toxicities Associated with the Onset of Cachexia. The Systemic Effects of Advanced Cancer 2022. [DOI: 10.1007/978-3-031-09518-4_8] [Reference Citation Analysis]
24 Geppert J, Walth AA, Terrón Expósito R, Kaltenecker D, Morigny P, Machado J, Becker M, Simoes E, Lima JDCC, Daniel C, Berriel Diaz M, Herzig S, Seelaender M, Rohm M. Aging Aggravates Cachexia in Tumor-Bearing Mice. Cancers (Basel) 2021;14:90. [PMID: 35008253 DOI: 10.3390/cancers14010090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Thibaut MM, Gillard J, Dolly A, Roumain M, Leclercq IA, Delzenne NM, Muccioli GG, Bindels LB. Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice. Cancers (Basel) 2021;13:6389. [PMID: 34945009 DOI: 10.3390/cancers13246389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Miyaguti NADS, Chiocchetti GME, Salgado CM, Lopes-Aguiar L, Viana LR, Blanchard L, Santos RWD, Gomes-Marcondes MCC. Walker-256 Tumour-Induced Cachexia Altered Liver Metabolomic Profile and Function in Weanling and Adult Rats. Metabolites 2021;11:831. [PMID: 34940589 DOI: 10.3390/metabo11120831] [Reference Citation Analysis]
27 Giovanelli L, Quinton R. Therapeutic effects of androgens for cachexia. Best Pract Res Clin Endocrinol Metab 2021;:101598. [PMID: 34801415 DOI: 10.1016/j.beem.2021.101598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Han J, Harrison L, Patzelt L, Wu M, Junker D, Herzig S, Berriel Diaz M, Karampinos DC. Imaging modalities for diagnosis and monitoring of cancer cachexia. EJNMMI Res 2021;11:94. [PMID: 34557972 DOI: 10.1186/s13550-021-00834-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Mcclement S. Adipose Tissue and Cancer Cachexia: What Nurses Need to Know. Asia Pac J Oncol Nurs 2021;8:445-9. [PMID: 34527774 DOI: 10.4103/apjon.apjon-2134] [Reference Citation Analysis]
30 Molfino A, Imbimbo G, Muscaritoli M. Role of metabolic changes of adiposity in cancer. Trends Endocrinol Metab 2021;32:957. [PMID: 34509360 DOI: 10.1016/j.tem.2021.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Russell L, Gramlich L. Challenges in parenteral nutrition in adult ultrashort gut: A case of cachexia. Nutr Clin Pract 2021. [PMID: 34468037 DOI: 10.1002/ncp.10756] [Reference Citation Analysis]
32 Demir S, Nawroth PP, Herzig S, Ekim Üstünel B. Emerging Targets in Type 2 Diabetes and Diabetic Complications. Adv Sci (Weinh) 2021;8:e2100275. [PMID: 34319011 DOI: 10.1002/advs.202100275] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
33 Morigny P, Kaltenecker D, Zuber J, Machado J, Mehr L, Tsokanos FF, Kuzi H, Hermann CD, Voelkl M, Monogarov G, Springfeld C, Laurent V, Engelmann B, Friess H, Zörnig I, Krüger A, Krijgsveld J, Prokopchuk O, Fisker Schmidt S, Rohm M, Herzig S, Berriel Diaz M. Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy. J Cachexia Sarcopenia Muscle 2021;12:1333-51. [PMID: 34427055 DOI: 10.1002/jcsm.12758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kong HH, Kim KW, Ko YS, Kim SC, Lee JH, Song KB, Hwang DW, Kim W. Longitudinal Changes in Body Composition of Long-Term Survivors of Pancreatic Head Cancer and Factors Affecting the Changes. J Clin Med 2021;10:3436. [PMID: 34362219 DOI: 10.3390/jcm10153436] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Gunadi JW, Welliangan AS, Soetadji RS, Jasaputra DK, Lesmana R. The Role of Autophagy Modulated by Exercise in Cancer Cachexia. Life (Basel) 2021;11:781. [PMID: 34440525 DOI: 10.3390/life11080781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Okuni I, Otsubo Y, Ebihara S. Molecular and Neural Mechanism of Dysphagia Due to Cancer. Int J Mol Sci 2021;22:7033. [PMID: 34210012 DOI: 10.3390/ijms22137033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
37 Verlande A, Chun SK, Goodson MO, Fortin BM, Bae H, Jang C, Masri S. Glucagon regulates the stability of REV-ERBα to modulate hepatic glucose production in a model of lung cancer-associated cachexia. Sci Adv 2021;7:eabf3885. [PMID: 34172439 DOI: 10.1126/sciadv.abf3885] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
38 Letarouilly JG, Flipo RM, Cortet B, Tournadre A, Paccou J. Body composition in patients with rheumatoid arthritis: a narrative literature review. Ther Adv Musculoskelet Dis 2021;13:1759720X211015006. [PMID: 34221129 DOI: 10.1177/1759720X211015006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
39 Chiocchetti GME, Lopes-Aguiar L, Miyaguti NADS, Viana LR, Salgado CM, Orvoën OO, Florindo D, Santos RWD, Cintra Gomes-Marcondes MC. A Time-Course Comparison of Skeletal Muscle Metabolomic Alterations in Walker-256 Tumour-Bearing Rats at Different Stages of Life. Metabolites 2021;11:404. [PMID: 34202988 DOI: 10.3390/metabo11060404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Mannelli M, Gamberi T, Magherini F, Fiaschi T. A Metabolic Change towards Fermentation Drives Cancer Cachexia in Myotubes. Biomedicines 2021;9:698. [PMID: 34203023 DOI: 10.3390/biomedicines9060698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Martin A, Freyssenet D. Phenotypic features of cancer cachexia-related loss of skeletal muscle mass and function: lessons from human and animal studies. J Cachexia Sarcopenia Muscle 2021;12:252-73. [PMID: 33783983 DOI: 10.1002/jcsm.12678] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
42 Kordes M, Larsson L, Engstrand L, Löhr JM. Pancreatic cancer cachexia: three dimensions of a complex syndrome. Br J Cancer 2021;124:1623-36. [PMID: 33742145 DOI: 10.1038/s41416-021-01301-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
43 Hitachi K, Nakatani M, Kiyofuji Y, Inagaki H, Kurahashi H, Tsuchida K. An Analysis of Differentially Expressed Coding and Long Non-Coding RNAs in Multiple Models of Skeletal Muscle Atrophy. Int J Mol Sci 2021;22:2558. [PMID: 33806354 DOI: 10.3390/ijms22052558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
44 Morigny P, Boucher J, Arner P, Langin D. Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics. Nat Rev Endocrinol 2021;17:276-95. [PMID: 33627836 DOI: 10.1038/s41574-021-00471-8] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 66.0] [Reference Citation Analysis]
45 Ballarò R, Lopalco P, Audrito V, Beltrà M, Pin F, Angelini R, Costelli P, Corcelli A, Bonetto A, Szeto HH, O'Connell TM, Penna F. Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia. Cancers (Basel) 2021;13:850. [PMID: 33670497 DOI: 10.3390/cancers13040850] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
46 Pötgens SA, Thibaut MM, Joudiou N, Sboarina M, Neyrinck AM, Cani PD, Claus SP, Delzenne NM, Bindels LB. Multi-compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice. J Cachexia Sarcopenia Muscle 2021;12:456-75. [PMID: 33599103 DOI: 10.1002/jcsm.12684] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
47 Berardi E, Madaro L, Lozanoska-Ochser B, Adamo S, Thorrez L, Bouche M, Coletti D. A Pound of Flesh: What Cachexia Is and What It Is Not. Diagnostics (Basel) 2021;11:116. [PMID: 33445790 DOI: 10.3390/diagnostics11010116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
48 Dantzer R, Casaril A, Vichaya E. Inflammation and Depression: Is Immunometabolism the Missing Link? Immuno-Psychiatry 2021. [DOI: 10.1007/978-3-030-71229-7_16] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Thibaut MM, Sboarina M, Roumain M, Pötgens SA, Neyrinck AM, Destrée F, Gillard J, Leclercq IA, Dachy G, Demoulin JB, Tailleux A, Lestavel S, Rastelli M, Everard A, Cani PD, Porporato PE, Loumaye A, Thissen JP, Muccioli GG, Delzenne NM, Bindels LB. Inflammation-induced cholestasis in cancer cachexia. J Cachexia Sarcopenia Muscle 2021;12:70-90. [PMID: 33350058 DOI: 10.1002/jcsm.12652] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
50 Saeteaw M, Sanguanboonyaphong P, Yoodee J, Craft K, Sawangjit R, Ngamphaiboon N, Shantavasinkul PC, Subongkot S, Chaiyakunapruk N. Efficacy and safety of pharmacological cachexia interventions: systematic review and network meta-analysis. BMJ Support Palliat Care 2021;11:75-85. [PMID: 33246937 DOI: 10.1136/bmjspcare-2020-002601] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
51 Masi T, Patel BM. Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison. Pharmacol Rep 2021;73:17-30. [PMID: 33141425 DOI: 10.1007/s43440-020-00179-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
52 Janovska P, Melenovsky V, Svobodova M, Havlenova T, Kratochvilova H, Haluzik M, Hoskova E, Pelikanova T, Kautzner J, Monzo L, Jurcova I, Adamcova K, Lenkova L, Buresova J, Rossmeisl M, Kuda O, Cajka T, Kopecky J. Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin. J Cachexia Sarcopenia Muscle 2020;11:1614-27. [PMID: 33084249 DOI: 10.1002/jcsm.12631] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
53 Olson B, Marks DL, Grossberg AJ. Diverging metabolic programmes and behaviours during states of starvation, protein malnutrition, and cachexia. J Cachexia Sarcopenia Muscle 2020;11:1429-46. [PMID: 32985801 DOI: 10.1002/jcsm.12630] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
54 Liu H, Luo J, Guillory B, Chen JA, Zang P, Yoeli JK, Hernandez Y, Lee II, Anderson B, Storie M, Tewnion A, Garcia JM. Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation via Ghrelin receptor-dependent and -independent pathways. Oncotarget 2020;11:3286-302. [PMID: 32934774 DOI: 10.18632/oncotarget.27705] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
55 Rohm M, Herzig S. An Antibody Attack against Body Wasting in Cancer. Cell Metab 2020;32:331-3. [PMID: 32877689 DOI: 10.1016/j.cmet.2020.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 T de Barros C, Rios AC, Alves TFR, Batain F, Crescencio KMM, Lopes LJ, Zielińska A, Severino P, G Mazzola P, Souto EB, Chaud MV. Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery. Int J Mol Sci 2020;21:E5974. [PMID: 32825177 DOI: 10.3390/ijms21175974] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
57 Siddiqui JA, Pothuraju R, Jain M, Batra SK, Nasser MW. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions. Biochim Biophys Acta Rev Cancer 2020;1873:188359. [PMID: 32222610 DOI: 10.1016/j.bbcan.2020.188359] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
58 Judge SM, Deyhle MR, Neyroud D, Nosacka RL, D'Lugos AC, Cameron ME, Vohra RS, Smuder AJ, Roberts BM, Callaway CS, Underwood PW, Chrzanowski SM, Batra A, Murphy ME, Heaven JD, Walter GA, Trevino JG, Judge AR. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer. Cancer Res 2020;80:1861-74. [PMID: 32132110 DOI: 10.1158/0008-5472.CAN-19-1558] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
59 Hitachi K, Nakatani M, Funasaki S, Hijikata I, Maekawa M, Honda M, Tsuchida K. Expression Levels of Long Non-Coding RNAs Change in Models of Altered Muscle Activity and Muscle Mass. Int J Mol Sci 2020;21:E1628. [PMID: 32120896 DOI: 10.3390/ijms21051628] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
60 Nishikawa H, Takata R, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S. Serum Zinc Level and non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases. JCM 2020;9:255. [DOI: 10.3390/jcm9010255] [Reference Citation Analysis]
61 Liu H, Luo J, Guillory B, Chen J, Zang P, Yoeli JK, Hernandez Y, Lee I(, Anderson B, Storie M, Tewnion A, Garcia JM. GHSR-1a is not Required for Ghrelin’s Anti-inflammatory and Fat-sparing Effects in Cancer Cachexia.. [DOI: 10.1101/866376] [Reference Citation Analysis]
62 Takata R, Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S. Association between Albumin-Bilirubin Grade and Non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases. JCM 2019;8:1485. [DOI: 10.3390/jcm8091485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Ose J, Gigic B, Lin T, Liesenfeld DB, Böhm J, Nattenmüller J, Scherer D, Zielske L, Schrotz-King P, Habermann N, Ochs-Balcom HM, Peoples AR, Hardikar S, Li CI, Shibata D, Figueiredo J, Toriola AT, Siegel EM, Schmit S, Schneider M, Ulrich A, Kauczor HU, Ulrich CM. Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study. Metabolites 2019;9:E178. [PMID: 31500101 DOI: 10.3390/metabo9090178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
64 Molfino A, Amabile MI, Giorgi A, Monti M, D’andrea V, Muscaritoli M. Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials. Expert Opinion on Investigational Drugs 2019;28:733-40. [DOI: 10.1080/13543784.2019.1646727] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]